Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Non-cash Items: 2023-2024

Historic Non-cash Items for Compass Therapeutics (CMPX) over the last 2 years, with Dec 2024 value amounting to $579,000.

  • Compass Therapeutics' Non-cash Items rose 29.17% to $15.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.5 million, marking a year-over-year increase of 29.17%. This contributed to the annual value of $579,000 for FY2024, which is 5163.64% up from last year.
  • Per Compass Therapeutics' latest filing, its Non-cash Items stood at $579,000 for FY2024, which was up 5,163.64% from $11,000 recorded in FY2023.
  • Compass Therapeutics' 5-year Non-cash Items high stood at $579,000 for FY2024, and its period low was $11,000 during FY2023.
  • Moreover, its 2-year median value for Non-cash Items was $295,000 (2023), whereas its average is $295,000.
  • Data for Compass Therapeutics' Non-cash Items shows a peak YoY surged of 5,163.64% (in 2024) over the last 5 years.
  • Over the past 2 years, Compass Therapeutics' Non-cash Items (Yearly) stood at $11,000 in 2023, then surged by 5,163.64% to $579,000 in 2024.